Global Plasma Albumin Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Plasma Albumin Market Research Report 2024
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
According to Mr Accuracy reports’s new survey, global Plasma Albumin market is projected to reach US$ 8367.1 million in 2029, increasing from US$ 5110 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Plasma Albumin market research.
The plasma albumin market is primarily driven by the increasing demand for albumin in various medical applications. Albumin, a crucial protein found in blood plasma, plays a vital role in maintaining osmotic pressure, transporting nutrients, and regulating pH levels. As a result, it finds extensive use in therapeutic treatments for conditions like hypovolemia, burns, liver cirrhosis, and septic shock. Additionally, the rising prevalence of chronic diseases and surgical procedures further fuels the demand for albumin as a vital component in various medical products and therapies.However, the market also faces challenges, such as the limited availability of human plasma-derived albumin and the strict regulatory guidelines for its collection and purification. Ensuring a stable and adequate supply of albumin can be challenging, especially during times of high demand or unforeseen events. Moreover, the development of alternative albumin sources, such as recombinant human albumin, presents both opportunities and challenges for the market. Overcoming these obstacles through advanced production methods, research, and collaboration within the healthcare industry will be essential in meeting the growing demand and maintaining a sustainable plasma albumin market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Plasma Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Segment by Type
20-25% Concentrations
5% Concentrations
Therapeutics
Excipient
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Plasma Albumin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Plasma Albumin market is projected to reach US$ 8367.1 million in 2029, increasing from US$ 5110 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Plasma Albumin market research.
The plasma albumin market is primarily driven by the increasing demand for albumin in various medical applications. Albumin, a crucial protein found in blood plasma, plays a vital role in maintaining osmotic pressure, transporting nutrients, and regulating pH levels. As a result, it finds extensive use in therapeutic treatments for conditions like hypovolemia, burns, liver cirrhosis, and septic shock. Additionally, the rising prevalence of chronic diseases and surgical procedures further fuels the demand for albumin as a vital component in various medical products and therapies.However, the market also faces challenges, such as the limited availability of human plasma-derived albumin and the strict regulatory guidelines for its collection and purification. Ensuring a stable and adequate supply of albumin can be challenging, especially during times of high demand or unforeseen events. Moreover, the development of alternative albumin sources, such as recombinant human albumin, presents both opportunities and challenges for the market. Overcoming these obstacles through advanced production methods, research, and collaboration within the healthcare industry will be essential in meeting the growing demand and maintaining a sustainable plasma albumin market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Plasma Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Segment by Type
20-25% Concentrations
5% Concentrations
Segment by Application
Therapeutics
Excipient
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Plasma Albumin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices